Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | -0.29% | -5.98% | +330.35% |
01:52pm | RBC Starts Perspective Therapeutics With Outperform Rating, $3 Price Target | MT |
05-09 | Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+330.35% | 1.02B | |
-5.28% | 182B | |
+2.27% | 111B | |
-2.97% | 68.48B | |
+1.07% | 49.69B | |
+7.92% | 44.46B | |
+2.33% | 40.67B | |
+22.43% | 31.22B | |
+2.13% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Isoray : Northland Capital Starts IsoRay at Outperform with $1.25 Price Target